Which patient groups have difficult-to-access veins?
Access is problematic for many patients, including:
Elderly patients with frail veins
Patients with a high BMI
Patients with darker skin tones
Patients with a current regime or history of chemotherapy treatments
Patients with collapsing or rolling veins
WHY I NEED VEINPLICITY
The first-attempt failure rate for adults in emergency settings ranges from 14 to 26% 1,2.
Failure rates are even higher in pediatric cases, ranging from
21 to 51% 3,4, depending on the setting.
1 Carr, P. J., et al (2016). The Journal of Vascular Access, 17(2): 182 – 190.
2 Lapostolle, F., et al (2007). Intensive Care Medicine, 33(8), 1452-1457.
3 Perry, A. M., et al (2011). Pediatric Emergency Care, 27(1), 5-10.
4 Hess, H. A. (2010). Pediatric Nursing, 36(5), 259.
There remains a large unmet medical need in the venous access arena.
While other options exist in the market, Veinplicity is a unique, effective technology that creates a physiological response in the veins, which assists healthcare providers in improving the rate of successful first-time access.
What are some of the adverse reactions?
Although venipuncture is considered to be reasonably safe, the difficulties and potential post-intervention complications arising from it can be high. Recurring failed attempts can lead to numerous adverse reactions, such as:
Patient anxiety, dizziness and pain
The potential for misleading blood results (e.g., potassium values) due to prolonged tourniquet constriction
Increased chance of infection (phlebitis, thrombophlebitis)
Infiltration/extravasation(the inadvertent administration of vesicant medication or solution into the surrounding tissue)
What is the current standard of care for gaining venous access?
Numerous peripheral venous access attempts are undertaken daily by healthcare professionals around the world. The most common device used to aid in gaining access is the tourniquet. This method has not significantly changed for over 80 years. However, the success rate for venous access varies greatly depending on the patient population.